President Obama is proposing "a major new initiative to develop drugs tailored to the genetic characteristics of individual patients, but he expresses deep concern about the costs of such specialty medicines for consumers and for the Medicare program," reports Robert Pear in April 27 New York Times. ...continue reading "Obama Proposes That Medicare Be Given the Right to Negotiate the Cost of Drugs"